A rapid, high-throughput viability assay for Blastocystis spp. reveals metronidazole resistance and extensive subtype-dependent variations in drug susceptibilities.
about
Update on the pathogenic potential and treatment options for Blastocystis spIn Vitro Antimicrobial Susceptibility Patterns of BlastocystisIntra-subtype variation in enteroadhesion accounts for differences in epithelial barrier disruption and is associated with metronidazole resistance in Blastocystis subtype-7Clinical pilot study: efficacy of triple antibiotic therapy in Blastocystis positive irritable bowel syndrome patientsBlastocystis, an unrecognized parasite: an overview of pathogenesis and diagnosisDifferential regulation of proinflammatory cytokine expression by mitogen-activated protein kinases in macrophages in response to intestinal parasite infection.Pyruvate:ferredoxin oxidoreductase and thioredoxin reductase are involved in 5-nitroimidazole activation while flavin metabolism is linked to 5-nitroimidazole resistance in Giardia lambliaPhenotypic and transcriptional profiling in Entamoeba histolytica reveal costs to fitness and adaptive responses associated with metronidazole resistanceA metronidazole-resistant isolate of Blastocystis spp. is susceptible to nitric oxide and downregulates intestinal epithelial inducible nitric oxide synthase by a novel parasite survival mechanism.Enteric protozoa in the developed world: a public health perspective.Blastocystis: Consensus of treatment and controversies.Identification of 23-(s)-2-amino-3-phenylpropanoyl-silybin as an antiviral agent for influenza A virus infection in vitro and in vivoBlastocystis Isolate B Exhibits Multiple Modes of Resistance against Antimicrobial Peptide LL-37.Understanding drug resistance in human intestinal protozoa.Perspective on the Genetic Response to Antiparasitics: A Review Article.Statin pleiotropy prevents rho kinase-mediated intestinal epithelial barrier compromise induced by Blastocystis cysteine proteases.Atorvastatin: In-Vivo Synergy with Metronidazole as Anti-Blastocystis Therapy.Blastocystis subtypes in symptomatic and asymptomatic family members and pets and response to therapy.Membrane Surface Features of Subtypes
P2860
Q27022138-773B73C2-2D6C-4D21-91B2-AF10FE21F9D2Q28262140-B0889D7A-8A62-418F-BADD-8AFD34541F21Q28539056-0E5FEB6E-FF2F-4266-A90D-8958B48598EAQ34404910-0E497A9D-2B1A-4A16-BF8B-875DB1DDAE23Q34435613-48F003D9-8ECA-4F27-B835-DF80E017052CQ34596044-CE59C1AA-D4F6-4DE8-A9B3-278125FB8E9FQ35096900-C05762D9-B572-4AE7-B71E-3F212F581911Q35569960-CF353F55-B076-46DC-AD99-1535A3A08612Q35598098-D34C9070-9166-4FC2-A836-B7809C00E42CQ36156094-68DFA37A-BE91-4166-9E67-C8CCC6B08199Q37100469-96AA47A5-6252-4D3E-8102-4A8789D7D017Q37124162-BFD636CF-38C9-4813-BD96-D1356D68184DQ37129880-1B01553D-B036-45C1-8178-027B6574B862Q38381784-E54E6AB7-AE47-4CF3-842E-B734A7B2C3D6Q47308561-9CEFBE0A-FC84-4399-89F6-41453DD0502AQ52625360-ADB1CB17-BD32-4450-BCFA-2DBEBAE64064Q53684271-4105C283-4C18-4CD6-9314-73CB46A410D6Q54342114-9DEAE043-C3AA-4E5F-A453-61C42F9E0080Q58768311-D9C005B3-864C-4EC9-A0AE-F75497095325
P2860
A rapid, high-throughput viability assay for Blastocystis spp. reveals metronidazole resistance and extensive subtype-dependent variations in drug susceptibilities.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
A rapid, high-throughput viabi ...... ions in drug susceptibilities.
@ast
A rapid, high-throughput viabi ...... ions in drug susceptibilities.
@en
A rapid, high-throughput viabi ...... ions in drug susceptibilities.
@nl
type
label
A rapid, high-throughput viabi ...... ions in drug susceptibilities.
@ast
A rapid, high-throughput viabi ...... ions in drug susceptibilities.
@en
A rapid, high-throughput viabi ...... ions in drug susceptibilities.
@nl
prefLabel
A rapid, high-throughput viabi ...... ions in drug susceptibilities.
@ast
A rapid, high-throughput viabi ...... ions in drug susceptibilities.
@en
A rapid, high-throughput viabi ...... ions in drug susceptibilities.
@nl
P2093
P2860
P356
P1476
A rapid, high-throughput viabi ...... ions in drug susceptibilities.
@en
P2093
Haris Mirza
Jacqui Upcroft
Joshua D W Teo
Kevin S W Tan
P2860
P304
P356
10.1128/AAC.00900-10
P407
P577
2010-11-22T00:00:00Z